Skip to content
Mytos logo

Mytos

Hiring

Mytos is a YC Summer 2018 (S18) company. Based in London, England, United Kingdom. Team of 26.

  • Hardware
  • IoT
  • Biotech
  • Automation
  • Biotechnology

About Mytos

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Mytos builds automated cell manufacturing systems for regenerative medicine producers. Its iDEM technology replicates the standard 2D flask process used in manual cell culture inside closed, automated hardware, converting stem cells into specific therapeutic cell types, such as neurons, corneal cells, and bone cells, over multi-week production runs. This replaces the skilled manual laboratory work that today makes stem-cell therapies too costly and slow to reach patients at scale.

Business model

A contract development and manufacturing (CDMO) service fee per batch, with no suite fees or device purchases

Go-to-market

Clinical-stage cell and gene therapy companies are the buyers; they engage Mytos through its CDMO service, which handles process development, manufacturing, and regulatory support under one roof at CGT Catapult's GMP facility.

From the Y Combinator listing

How Mytos describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Robotic human cell manufacturing

Mytos builds robots for manufacturing human cells. Operators input stem cells, and our platform turns them into specific cells such as neurons and heart cells over multiple weeks. Last year, patients were cured of Parkinson’s, vision loss, and Type 1 diabetes using stem-cell derived cells. We need 1000x the global capacity to produce these cells, and treat millions of patients. But today these Regenerative Medicines are produced by hand, meaning they’re too expensive and don’t scale. Mytos has fully automated production of these cells, making it scalable. We have our first manufacturing deal - neurons for treating Parkinson’s - and we’re in conversations with majority of the other top players.

Facts

Industry
Healthcare / Healthcare -> Industrial Bio
Location
London, England, United Kingdom
Team size
26
Status
Active
Stage
Early

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works